,24,25,26,27,28,29 Several oncolytic adenoviruses that express granulocyte-macrophage colony stimulating factor (GM-CSF)30 or OX40L31 have shown promise in treatment of melanoma in animal models and phase I clinical trials.32 The gene discussed is CSF2; the disease is melanoma.